The univariable Cox proportional hazard model identified a significantly increased HR for drug discontinuation in patients who used IL-17 inhibitors for reasons other than psoriasis aggravation (HR: 2.38, 95% CI: 1.08–5.20, P = 0.031). Here, IL17A is linked to psoriasis.